Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
10 Maio 2023 - 5:30PM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the
Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday,
June 13th, at the Waldorf Astoria Monarch Beach Resort & Club
in Dana Point, CA. Biljana Naumovic, Worldwide Vice President,
Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology,
will represent the Company in a session scheduled at 4:20 p.m.
(Eastern Time).
This webcast will be available to investors and other interested
parties by accessing the Johnson & Johnson website at
www.investor.jnj.com.
A webcast replay will be available approximately 48-hrs after
the live webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230510005666/en/
Investor: RA-JJCUS-InvestorRel@ITS.JNJ.com Media:
media-relations@its.jnj.com
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024